WOLVERINE ASSET MANAGEMENT LLC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 27 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$36,000
-34.5%
28,789
+8.7%
0.00%
Q3 2017$55,000
+1.9%
26,474
+41.6%
0.00%
-100.0%
Q2 2017$54,000
-37.9%
18,700
-27.0%
0.00%0.0%
Q1 2017$87,000
-22.3%
25,600
-60.6%
0.00%0.0%
Q4 2016$112,000
-41.7%
64,900
+11.9%
0.00%
-66.7%
Q3 2016$192,00058,0000.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 542,755$944,0000.47%
BVF INC/IL 734,976$1,279,0000.26%
Old West Investment Management, LLC 206,018$358,0000.22%
Foresite Capital Management III, LLC 254,257$442,0000.19%
Baupost Group 2,226,839$3,875,0000.05%
Rhenman & Partners Asset Management AB 120,000$209,0000.04%
NEA Management Company, LLC 370,900$645,0000.03%
Rock Springs Capital Management LP 165,300$288,0000.02%
TWO SIGMA SECURITIES, LLC 22,934$40,0000.01%
Telemetry Investments, L.L.C. 10,250$18,0000.01%
View complete list of OREXIGEN THERAPEUTICS INC shareholders